Academics
follow us
  • Linkedin
  • Twitter
  • Facebook
  • Youtube
  • Instagram
Feedback
Patent Number:- IN369080

Apremilast Loaded Liquid Crystalline Nanoparticles for Topical Delivery in the Treatment of Psoriasis

  • Sector: Pharmaceutical Technology,
  • IPC: A61K, C07D, A61Q,
 

Need

There is a need for a carrier system capable of efficiently delivering drug molecules to targeted skin layers to reduce adverse effects.

Solution

The invention presents a process for preparing lipid-based nanocarriers for drug delivery, particularly for apremilast, enhancing topical treatment effectiveness.

Innovation

Developing a process involving specific temperature-controlled steps to create lipid-based nanocarriers for drug delivery, addressing challenges in targeted topical treatment.

Market Analysis

Market: Dermatological Treatments, specifically Psoriasis

CAGR: potential for significant growth due to innovation and process improvement

Potential Indian Clients: Dermatology clinics, pharmaceutical companies specializing in skin care products

Why Invest?


Psoriasis

Apremilast

Encapsulation efficiency

Lipid-based

At a Glance


Current TRL: NA

Funded by: NA

IPC: A61K, A61Q, C07D

Domain: Topical Drug Delivery Systems

For more information, reach out to Mr. Rajneesh Kumar, Head of the Technology Transfer Office, at tto@bits-pilani.ac.in and 01596-255515.